secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2022-09-09T23:59:59+00:00
Accession:  0001178913-22-003369
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio shareholders elect Yonatan Malca and approve all proposals at 2022 annual meeting
--------------------------------------------------------------------------------

- Yonatan Malca elected to board for three-year term; 11,060,520 votes for, 47,457 against.
- CEO Miranda Toledano's compensation ratified: 8,074,581 for, 2,959,002 against.
- Amendment to 2018 equity plan increasing shares by 576,188 approved: 8,420,408 for.
- Kesselman & Kesselman (PwC) ratified as auditor for FY2022 with 11,061,302 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322003369/0001178913-22-003369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322003369/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001178913-22-003369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer